9 November 2021 - Proposals for a national entity to produce and assess evidence about the relative value of medical technology ...
2 July 2021 - The controversial approval last month by the FDA of Aduhelm (aducanumab) for patients with early-stage Alzheimer’s disease ...
25 May 2021 - ICER’s analysis, based on MMIT’s market access analytics solution, will evaluate how 15 of the largest ...
26 April 2021 - Informed by expert input from patient groups, former regulators, payers, and life science companies, white paper analyses ...
2 July 2020 - The Institute for Clinical and Economic Review today published a white paper to inform public and policy ...
15 March 2018 - Systemic factors in the US health care system lead to greater pricing power for drug manufacturers than ...